Aziz Ansari, an award-winning actor, director, writer and comedian, brings his “Hypothetical Tour” to the Gallo Center. He co ...
Zacks Investment Research on MSN
VRTX's New Drugs Performance Mixed in Q3: Can Their Sales Improve?
Vertex Pharmaceuticals Incorporated’s VRTX third-quarter 2025 results were strong as it beat estimates for both earnings and ...
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...
Emerging biotechnologies, strategic collaborations, and growing focus on personalized and regenerative medicine are accelerating the next wave of gene therapy innovation.Austin, Nov. 05, 2025 (GLOBE ...
Cathie Wood's ARK Invest bought $17M in CRISPR and Beam gene-editing stocks while selling Teradyne, Roku, and SoFi shares on ...
Genetically modified organisms, also known as GMOs, have been a hot topic of conversation among researchers, producers, ...
Cathie Wood's Ark Invest sold shares of five biotech and healthcare companies in recent trades. She also offloaded over 1.1 ...
Our new but simple method is far more effective and can now be applied to a much wider range of plant species than our ...
A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate ...
A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results